Email Artikel ini REVIEW ARTIKEL :WARFARIN DAN INTERAKSINYA DENGAN OBAT OBAT LAIN (ANTIDEPRESAN, ANTIBIOTIK, ANTIINFLAMASI NONSTEROID, DAN PARASETAMOL)
Abstrak
Teks Lengkap:
PDFReferensi
Ament, P.W., J.G. Bertolino and J.L. Liszewski. 2000. Clinically Significant Drug Interactions. Am Fam Physician, Vol 61 (6): 1745 – 54.
Bachawati, M. 2010. Anticoagulation and Psychotropic Medications. Curr Psychiatry Rep, Vol 12 (3): 265 – 71.
Bertolini,A., A. Ferrari, A. Ottani, S. Guerzoni, R. Tacchi and S. Leone. 2007. Paracetamol: New Vistas of an Old Drug. CNS Drug Rev, Vol 12 (3): 250 -75.
Choi, K.H., A.J. Kim, I.J. Son, K.K. Hwan, K.K Bong, H. Ahn, et al. 2010. Risk Factor of Drug Interaction between Warfarin and Nonsteroidal Anti-Inflammatory Drugs in Practical Setting. J Korean Med Sci, Vol 25 (3): 337 – 41.
Cozza and Armstrong. 2001. Drug Interaction Principles for Medical Practice. Washington: American Psychiatric Publishing.
Dean, L. 2012. Warfarin Therapy and VKORC1 and CYP Genotype. Available from https://www.ncbi.nlm.nih.gov/books/NBK84174/ [Accessed on July 2nd 2018]
Delaney, J.A., L. Opatrny, J.M. Brophy and S. Suissa. 2007. Drug Drug Interaction between Antithrombotic Medications and The Risk of Gastrointestinal Bleeding. CMAJ, Vol 177(4): 347 – 51.
Fischer, H.D., D.N. Juurlink, M.M. Mamdani, A. Kopp and A. Laupacis. 2010. Hemorrhage During Warfarin Therapy Associated with Contrimoxazole and Other Urinanry Tract Anti-infective Agent. Arch Intern Med, Vol 170 (7): 617 – 21.
Forbes, H.L., and T.M. Polasek. 2017. Potential Drug-Drug Interaction with Direct Oral Anticoagulants in Ederly Hospitalized Patient. Ther Adv Drug Saf , Vol 8 (10): 319 - 28.
Ghaswalla, P.K., S.E. Harpe, D. Tassone and P.W. Slattum. 2012. Warfarin-Antibiotic Interactions in Older Adult of an Outpatient Antikoagulan Clinic. The American Journal of Geriatric Pharmacotherapy, Vol 10 (6): 352- 60.
Goodman and Gilman. 2008. Manual of Pharmacology and Therapeutics. California: Mc-Graw Hill.
Ho, L.H., and T. Brighton. 2002. Warfarin, Antiplatelet Drugs and Their Interactions. Aust Prescr, Vol 25 (4): 81-5.
Jacobs, L.G. 2008. Warfarin Pharmacology, Clinical Management, and Evaluation of Hemorrhagic Risk for the Elderly. Cardiol Clin, Vol 26 (2): 157 – 67.
Johnson, J.A., L. Gong., M.W. Carillo, B.F. Gage, S.A. Scott, C.M. Stein, et al. 2011. Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and VKORC1 Genotypes and Warfarin Dosing. Clin Pharmacol Ther, Vol 90 (4): 625 – 29.
Launiainen, T., A. Sajantila, and I. Rasanen, E. Vuori and I. Ojanpera. 2010. Adverse Interaction of Warfarin and Paracetamol: Evidence From a Post-Mortem Study. European Journal of Clinical Pharmacology, Vol 66 (1): 97-103.
Lopes, R.D., J.D. Horowiz, D.A. Garcia, M.A. Crowther and E.M. Hylek. 2011. Warfarin and Acetaminophen Interaction : A Summary of The Evidence and Biologic Plausibility. Blood, 118 (24): 6269 -73.
Monastero, R., R. Camarda and C. Camarda. 2007. Potential Drug-Drug Interaction Between Duloxetine and Acenocoumarol in a Patient with Alzheimers Disease. Clinical Therapeutics, Vol 29 (12) : 2706 – 09.
Nelson, W.W., Wang, L., O. Baser, C.V. Damaraju and J.R. Schein. 2015. Out-of-Range INR Values and Outcomes among New Warfarin Patient with Non-Valvular Atrial Fibrillation. Int J Clin Pharm 37 (1): 53-9.
Oden, A and M. Fahlen. 2002. Oral Anticoagulation and Risk of Death: a Medical Record Linkage Study. BMJ, Vol 325(7372) : 1073-5.
Opatrny, L., J.A.C. Delaney and S. Suissa. 2008. Gastro-intestinal Haemorrhage Risks of Selective Serotonin Receptor Antagonist Therapy: A New Look. British Journal Clinical Pharmacology, Vol 66 (1): 76-81.
Preskorn, S., S.B. Gonzales, and D. Flockhart. 2006. Clinically Relevant Pharmacology of Neuropsychiatric Drugs Approved Over the Last Three Years: Part II. Journal of Psychiatric Practice, Vol 12 (5): 312 – 6.
Sansone, R.A., and L.A. Sansone. 2009. Warfarin and Antidepressants. Psychiatry (Edgmont), Vol 6 (7): 24 -9.
Sayal, K.S., D. McConnel, H.W. McConnel, and D.M. Taylor. 2000. Psychotropic Interactions with Warfarin. Acta Psychiatr Scand, Vol 102 (4): 250 - 5.
Shalansky, S., L. Lynd, K. Richardson, A. Ingaszewski and C. Kerr. 2007. Risk of Warfarin-related Bleeding Events and Supratherapeutic International Normalized Ratios Associated with Complementary and Alternative Medicine: a Longitudinal Analysis. Pharmacotherapy, Vol 27 (9): 1237 – 47.
Teklay, G., N. Shiferaw, B. Legesse and M.L. Bekele. 2014. Drug – Drug Interactions and Risk of Bleeding among Inpatients on Warfarin Therapy: a Prospective Observational Study. Thrombosis Journal, 12 (20): 1 – 8.
Vieira, M.D.L.T, and S.M. Huang. 2012. Botanical-Drug Interactions: a Scientific Perspective. Planta Medica, Vol 78(13): 1400 – 15.
Wardrob, D., and D. Keeling. 2008. The Story of the Discovery of Heparin and Warfarin. British Journal of Haematology, Vol 141 (6): 757 – 63.
Wittkowsky, A.K., S.J. Boccuzzi, J. Wogen, G. Wygant, P. Patel and O. Hauch. 2004. Frequency of Concurrent Use of Warfarin with Potentially Interacting Drugs. Pharmacotherapy, Vol 24 (12): 1668 – 74.
DOI: https://doi.org/10.24198/jf.v16i1.17427
DOI (PDF): https://doi.org/10.24198/jf.v16i1.17427.g8629
Refbacks
- Saat ini tidak ada refbacks.
Sitasi manajer:
Jurnal ini diindeks dalam:
Farmaka by Universitas Padjadjaran is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Copyright © 2013 Jurnal Farmaka - All Right Reserved